Selenium Toxicity / Selenosis

Selenium toxicity, also known as selenosis, in horses represents a serious condition resulting from excessive selenium intake through dietary sources, supplementation errors, or consumption of selenium-accumulating plants. Selenium is an essential trace mineral required for normal physiological function, playing critical roles in antioxidant systems and thyroid hormone metabolism. However, the margin between adequate and toxic selenium intake is narrow, and horses are particularly susceptible to the adverse effects of selenium excess. The condition manifests through characteristic damage to rapidly growing tissues including the hooves and hair, neurological dysfunction in acute cases, and potentially fatal cardiac and respiratory effects in severe toxicity.

The prevalence of selenium toxicity in horses varies dramatically by geographic region, with the condition being most common in areas with naturally high soil selenium content. The Great Plains states of the United States, particularly South Dakota, Wyoming, Montana, Nebraska, and portions of surrounding states, are historically associated with seleniferous soils and selenium accumulator plants that have caused livestock poisoning for over a century. However, selenium toxicity also occurs outside these endemic regions when horses receive excessive supplementation, particularly through errors in feed manufacturing, inappropriate use of injectable selenium products, or over-supplementation by well-meaning owners concerned about selenium deficiency.

The impact of selenium toxicity on equine health is profound and potentially permanent, particularly affecting the hooves and hair coat. Chronic selenium toxicity causes disruption of keratin formation, resulting in horizontal hoof wall cracks that may progress to complete separation and sloughing of the hoof capsule. Hair becomes brittle and breaks easily, with characteristic loss of the mane and tail hair. Acute high-dose exposure causes a different syndrome dominated by neurological signs including blindness, head pressing, and ataxia, historically termed blind staggers. Severe acute toxicity can cause sudden death from myocardial failure. The economic impact includes treatment costs, prolonged disability, and potential permanent unsoundness.

Selenium toxicity is manageable when recognized early and the source of excess selenium is eliminated, but severe cases with extensive hoof damage or cardiac involvement carry guarded prognosis. Prevention through appropriate selenium management is essential, particularly in known seleniferous areas where horses should not have access to accumulator plants and supplementation should be carefully controlled. Horse owners must understand that selenium deficiency and toxicity are both serious conditions, and that supplementation should be based on regional considerations, dietary analysis, and veterinary guidance rather than assumptions or general recommendations. Early recognition of the characteristic signs of selenosis allows intervention before irreversible damage occurs.

The primary cause of selenium toxicity in horses is ingestion of selenium at levels exceeding the body's capacity for safe metabolism and excretion. The toxic threshold for selenium in horses is approximately 5 milligrams per kilogram of diet, while the dietary requirement is only 0.1 to 0.3 milligrams per kilogram. This relatively narrow margin between adequate and toxic intake creates opportunity for toxicity through several pathways. Geographic factors create the foundation for many cases, as certain regions have naturally high selenium soil content that transfers to locally grown forages and creates endemic areas of selenosis risk. Supplementation errors represent another major cause, occurring when horses receive multiple selenium-containing products, when supplements are improperly formulated, or when injectable selenium is administered inappropriately.

Consumption of selenium-accumulating plants represents the classic cause of selenium toxicity in endemic regions. Certain plant species have the ability to concentrate selenium from the soil to levels many times higher than surrounding vegetation, creating toxic hazards for grazing horses. Primary selenium accumulators including species of Astragalus, Stanleya, Oonopsis, and Xylorrhiza can contain thousands of parts per million of selenium, making consumption of even small quantities potentially toxic. Secondary accumulators including some grasses and forbs reach lower but still dangerous selenium concentrations when growing in seleniferous soils. Horses may be forced to consume these plants when pastures are overgrazed or when drought conditions reduce availability of preferred forages.

Supplementation-related selenium toxicity has become increasingly recognized as selenium supplementation has become routine in many equine management programs. Feed manufacturing errors can result in selenium concentrations many times higher than intended in commercial feeds or supplements. Administration of injectable selenium products at excessive doses or frequencies causes acute high-dose exposure. Concurrent use of multiple selenium-containing products including vitamin E-selenium supplements, complete feeds, and trace mineral mixtures can result in cumulative intake exceeding safe levels. Well-intentioned supplementation in selenium-adequate or selenium-excess regions creates iatrogenic toxicity.

Risk factors for selenium toxicity relate to both geographic location and management practices. Horses in known seleniferous regions face inherent risk from environmental selenium exposure. Horses receiving multiple feeds and supplements from different sources may receive excessive cumulative selenium without individual products appearing to exceed recommended levels. Horses under the care of multiple individuals who are not communicating about supplementation may receive duplicate doses. Young growing horses may be more susceptible to the developmental effects of selenium toxicity. Horses with limited grazing options in drought conditions may be forced to consume accumulator plants they would otherwise avoid.

The pathophysiology of selenium toxicity involves replacement of sulfur with selenium in sulfur-containing amino acids, disrupting normal protein structure and function. Selenium substitutes for sulfur in cysteine and methionine, amino acids critical for keratin structure in hooves and hair. This substitution results in weak, abnormal keratin that cannot maintain normal structural integrity, explaining the characteristic hoof and hair abnormalities of chronic selenosis. Acute toxicity affects multiple organ systems through oxidative damage and enzyme dysfunction. Cardiac muscle is particularly sensitive to selenium toxicity, with myocardial necrosis causing cardiac failure in severe cases. Neurological effects result from both direct neural toxicity and secondary effects of impaired myelin formation and neurotransmitter synthesis.

Early warning signs of chronic selenium toxicity in horses typically develop gradually over weeks to months of excess selenium intake and may be subtle initially. Changes in hoof quality represent one of the earliest indicators, with affected horses developing increased hoof brittleness, cracking, or abnormal growth patterns before obvious defects appear. Hair coat changes may include loss of normal luster, increased breakage, or beginning thinning of mane and tail before dramatic hair loss occurs. Mild lameness or stiffness may develop as hoof integrity begins to deteriorate. Decreased appetite or vague signs of not thriving may be noticed before more specific symptoms appear. Astute observers may note that horses seem uncomfortable or reluctant to move on hard surfaces.

Common symptoms of established chronic selenium toxicity produce the classic syndrome historically termed alkali disease. Horizontal cracks develop in the hoof wall, creating distinct separation lines that correspond to periods of selenium excess. These cracks may progress to complete circumferential separation, eventually causing partial or complete sloughing of the hoof wall in severe cases. Lameness ranges from mild discomfort to severe inability to bear weight depending on the extent of hoof damage. Hair loss affects the mane and tail most prominently, with characteristic thinning and breakage leaving sparse, short, broken hairs. The long hairs of the fetlocks and coronary band may also be lost. Weight loss develops from decreased feed intake and the metabolic stress of chronic toxicity.

Behavioral changes in horses experiencing selenium toxicity reflect both physical discomfort and systemic illness effects. Horses with hoof damage show reluctance to move, shortened stride length, and preference for soft footing. Depression and decreased interaction with handlers and herdmates accompanies chronic illness. Reduced appetite contributes to declining body condition. Horses may show changes in normal grooming and social behaviors. In acute toxicity with neurological involvement, dramatic behavioral changes including apparent blindness, disorientation, and abnormal behavior patterns develop rapidly.

Physical signs of selenium toxicity depend on whether exposure is chronic or acute. Chronic toxicity produces the characteristic hoof changes with horizontal cracking, separation, and potential sloughing. Hair coat abnormalities including mane and tail loss with broken stubble are diagnostic. Coronary band inflammation and sensitivity may be palpable. Body condition declines with visible weight loss. Acute high-dose toxicity causes a different syndrome including garlic odor to breath from volatile selenium compounds, excessive salivation, respiratory distress, diarrhea, and cyanosis. Neurological signs in acute toxicity include ataxia, apparent blindness, head pressing, and seizures in the syndrome termed blind staggers.

Symptom progression in chronic selenium toxicity follows a gradual course as cumulative tissue damage accumulates. Early mild hoof abnormalities progress to obvious horizontal cracking. Cracks deepen and may develop secondary infection. Progressive lameness reflects worsening hoof structural integrity. Hair loss becomes increasingly obvious as more hair breaks and falls out. Body condition deteriorates as chronic pain and illness affect feed intake and metabolism. In severe cases, complete hoof wall separation may occur, essentially causing the horse to lose its hooves. Secondary infections of damaged hoof structures can cause sepsis. Acute toxicity progresses more rapidly from initial neurological signs to cardiac arrhythmias, respiratory failure, and potential sudden death.

Emergency symptoms requiring immediate veterinary care include any signs of acute selenium toxicity such as sudden onset of neurological abnormalities, garlic-scented breath, respiratory distress, or signs of cardiac compromise. Horses showing severe lameness with obvious hoof structural failure require urgent attention. Signs of secondary infection in damaged hooves including heat, swelling, and purulent discharge need immediate treatment. Profound weakness, recumbency, or cardiovascular instability indicates severe toxicity requiring emergency intervention. Any horse with known recent exposure to high selenium doses through injectable products or accidental ingestion should receive immediate veterinary evaluation regardless of current symptoms.

Physical examination of horses suspected of selenium toxicity focuses on identifying the characteristic tissue changes and assessing overall health status. Careful examination of all four hooves evaluates for horizontal cracks, separation lines, coronary band abnormalities, and structural integrity of the hoof wall. Assessment of hair coat quality notes thinning, breakage, and loss patterns affecting the mane, tail, and feathered areas. Body condition scoring documents any weight loss. Neurological examination evaluates for signs of central or peripheral nervous system involvement. Cardiovascular assessment including heart rate, rhythm, and auscultation identifies any cardiac abnormalities. Complete history including geographic location, diet composition, supplements administered, and recent treatments helps establish potential selenium exposure sources.

Diagnostic tests for selenium toxicity provide objective confirmation of excess selenium status and assess for secondary complications. Whole blood selenium levels directly measure current selenium status, with values exceeding 1.0 parts per million indicating toxicity risk and values above 2.0 parts per million confirming toxicity. Hair and hoof selenium analysis provides information about historical selenium status over the growth period of the sampled tissue. Complete blood count may reveal anemia or inflammatory changes. Serum biochemistry evaluates liver and kidney function, as selenium is metabolized hepatically and excreted renally. Cardiac biomarkers including troponin may be elevated with myocardial damage. Muscle enzyme elevations suggest concurrent muscle damage.

Advanced diagnostics help characterize the extent of selenium-induced damage. Radiographs of affected feet evaluate for bony changes, abscessation, or sequestrum formation secondary to hoof damage. Echocardiography assesses cardiac function in horses with suspected myocardial involvement. Electrocardiography identifies arrhythmias associated with selenium cardiotoxicity. Biopsy of affected tissues can confirm the diagnosis but is rarely necessary when clinical signs and selenium levels are consistent. Analysis of feed, water, and forage samples from the horse's environment helps identify the selenium source and guide management changes.

Differential diagnosis for selenium toxicity depends on the presenting syndrome. Chronic selenosis with hoof and hair changes must be distinguished from other causes of hoof wall defects including chronic laminitis, white line disease, and nutritional deficiencies. Conditions causing hair loss include dermatophytosis, Cushing's disease, and other endocrine disorders. Acute selenium toxicity with neurological signs requires differentiation from other causes of acute neurological dysfunction including hepatic encephalopathy, equine protozoal myeloencephalitis, rabies, and various toxicities. The combination of characteristic hoof and hair changes with elevated selenium levels in appropriate geographic or supplementation context establishes the diagnosis of chronic selenosis.

Emergency and immediate treatment for acute selenium toxicity focuses on supportive care and prevention of further absorption. There is no specific antidote for selenium poisoning, making treatment largely supportive. Activated charcoal may be administered if ingestion is recent to reduce further absorption from the gastrointestinal tract. Intravenous fluid therapy supports cardiovascular function and promotes renal excretion of selenium. Cardiac monitoring identifies arrhythmias requiring specific treatment. Respiratory support including oxygen supplementation may be necessary for horses with respiratory compromise. Seizure control using diazepam or other anticonvulsants addresses neurological manifestations. The source of selenium exposure should be identified and eliminated immediately.

Medical management of chronic selenium toxicity centers on eliminating the selenium source and supporting the horse through recovery. All selenium-containing supplements should be discontinued immediately. Feed and forage sources should be evaluated and changed if they contribute to excess selenium intake. Horses in seleniferous regions should be removed from pastures containing accumulator plants. High-protein diets may help by providing sulfur-containing amino acids that compete with selenium for incorporation into proteins. Some practitioners recommend supplementation with inorganic sulfur, copper, or high-sulfur amino acids to promote selenium excretion and compete with selenium in metabolic pathways.

Hoof care is a critical component of treatment for horses with selenium-induced hoof damage. Consultation with an experienced farrier is essential for managing compromised hoof structures. Protective hoof boots or casts may be necessary to maintain structural support while damaged hoof wall grows out. Therapeutic shoeing can redistribute weight away from damaged areas. Treatment of secondary infections with appropriate antimicrobials addresses complications. Pain management using appropriate analgesics maintains comfort and mobility. Complete regrowth of the hoof wall requires nine to twelve months, during which careful management prevents further deterioration.

Supportive care addresses the multiple system effects of selenium toxicity. Nutritional support ensures adequate caloric intake and provides balanced nutrition without excessive selenium. Weight management through appropriate diet helps horses recover body condition lost during illness. Environmental modifications including soft footing reduce stress on damaged hooves. Protection from weather extremes minimizes additional physiological stress. Wound care for any areas of hoof separation prevents secondary infection. Physical therapy and controlled exercise maintain muscle condition within the limitations imposed by hoof damage.

Rehabilitation and return to function following selenium toxicity requires extended time for tissue regeneration. Hoof wall regrowth proceeds at approximately one centimeter per month, requiring a year or more for complete replacement of damaged structures. Hair regrowth begins once selenium levels normalize but may take months to restore normal mane and tail appearance. Gradual return to exercise follows resolution of lameness and restoration of hoof structural integrity. Cardiac function should be evaluated before returning horses with suspected myocardial involvement to athletic activity.

Treatment decisions for selenium toxicity must consider the severity of tissue damage and realistic expectations for recovery. Mild cases with early recognition and intervention carry good prognosis for full recovery. Moderate hoof damage may heal with extended management but may leave horses with permanent structural weaknesses. Severe cases with complete hoof wall loss or extensive sloughing face prolonged disability and uncertain prognosis. Horses with significant cardiac damage may not be suitable for future athletic use. Euthanasia may be appropriate for horses with intractable pain, complete hoof loss, or cardiac failure that cannot be managed. Honest assessment of long-term quality of life considerations should guide treatment planning.

Recovery timeline for horses with selenium toxicity varies substantially based on the severity and type of tissue damage. Normalization of blood selenium levels typically occurs within weeks to a few months of eliminating the selenium source, depending on body stores and ongoing dietary intake. Hair regrowth begins as new hair follicle activity resumes, with visible improvement in mane and tail density occurring over three to six months and full restoration potentially requiring a year or more. Hoof regeneration follows the normal growth rate of approximately eight to ten millimeters per month, meaning complete replacement of a damaged hoof wall requires nine to fifteen months depending on hoof length.

Post-treatment care and monitoring for horses recovering from selenium toxicity requires consistent attention throughout the extended healing period. Serial blood selenium measurements confirm that levels are normalizing and that dietary changes have effectively reduced intake. Regular hoof evaluation by a veterinarian and farrier tracks healing progress and identifies any complications requiring intervention. Documentation of new hoof growth through photographs or measurements provides objective evidence of improvement. Body condition should be monitored to ensure nutritional adequacy during recovery. Any signs of deterioration or complications should prompt immediate veterinary assessment.

Prognosis factors for selenium toxicity include the severity of tissue damage at presentation, the promptness of intervention, and the completeness of source elimination. Horses with mild chronic toxicity presenting with early hoof changes and elevated but not extreme selenium levels typically carry favorable prognosis for full recovery. Moderate cases with established horizontal cracking but intact hoof wall structure usually recover but may retain some structural weakness. Severe cases with partial or complete hoof wall sloughing face guarded prognosis for return to athletic function and may require extended or permanent supportive care. Horses with cardiac involvement from acute toxicity have variable prognosis depending on the extent of myocardial damage.

Long-term soundness outlook for horses recovering from selenium toxicity depends on the extent of permanent structural damage to hooves and other tissues. Many horses with mild to moderate damage achieve full recovery and return to their previous level of work once hoof regeneration is complete. Some horses retain permanent hoof wall weakness or abnormalities that may predispose to future problems or limit athletic performance. Horses that experienced complete hoof wall loss may regrow functional hooves but often have permanent abnormalities affecting soundness. Cardiac function recovery is variable, with some horses returning to normal function while others retain permanent limitations. Regular long-term monitoring helps identify any delayed complications.

Management practices to prevent selenium toxicity require understanding of regional selenium status and appropriate supplementation strategies. Horse owners in known seleniferous regions should be aware of the inherent risk and avoid supplementing selenium without documented deficiency. In selenium-adequate or selenium-excess areas, selection of feeds and supplements should specifically avoid additional selenium. Forage analysis provides objective data about selenium content of locally grown hay and pasture. Water testing may be warranted in areas with known high environmental selenium. Communication with veterinarians and nutritionists familiar with local conditions helps establish appropriate supplementation programs.

Pasture and grazing management in seleniferous regions aims to prevent access to selenium accumulator plants. Identification of accumulator species present on the property enables targeted management. Maintaining adequate pasture quality through proper stocking rates and rotational grazing reduces the likelihood that horses will consume less palatable accumulator plants. Mechanical removal or herbicide treatment of accumulator plant populations reduces pasture contamination. Providing adequate hay or other forages reduces grazing pressure that might force consumption of toxic plants. Fencing horses away from areas with heavy accumulator plant growth provides physical prevention of access.

Supplementation safety requires careful attention to total selenium intake from all sources. A complete inventory of all feeds, supplements, and treatments containing selenium allows calculation of total daily intake. Comparison of total intake against requirements and toxic thresholds identifies potential excess. Avoiding duplication of selenium sources when using multiple products reduces cumulative risk. Verification of supplement concentrations and feeding rates ensures accurate dosing. Injectable selenium products should be used only when clearly indicated and at appropriate doses and intervals. Communication among all individuals involved in a horse's care prevents inadvertent duplicate supplementation.

Monitoring of selenium status through periodic blood testing helps identify developing problems before clinical signs appear. Baseline selenium levels establish individual normal values and regional norms. Regular monitoring in horses at risk allows early detection of increasing selenium status before toxicity develops. Testing of horses newly arrived from other regions helps identify those coming from selenium-deficient areas that might need supplementation versus those from selenium-adequate or excess areas. Clinical monitoring for early signs of selenosis including subtle hoof or hair changes enables intervention before significant damage occurs.

Education and awareness about selenium toxicity is essential for horse owners and equine professionals in all regions. Understanding that selenium is both essential and potentially toxic promotes appropriate respect for proper supplementation. Recognition of regional variation in selenium status helps owners and veterinarians make informed decisions about supplementation needs. Knowledge of clinical signs of both deficiency and toxicity enables appropriate monitoring. Understanding that more is not better regarding selenium supplementation helps prevent well-intentioned iatrogenic toxicity.

Daily management adjustments for horses recovering from selenium toxicity focus on supporting tissue healing while preventing re-exposure. Feeding programs should emphasize low-selenium feeds appropriate for the geographic region, with careful verification of selenium content in all feed components. Daily observation of hooves monitors healing progress and identifies any developing complications. Hair coat condition should be noted for signs of regrowth or any deterioration suggesting ongoing exposure. Appetite and overall attitude assessment identifies any setbacks in recovery. Medication and supplement administration should follow prescribed schedules exactly, with particular attention to avoiding any inadvertent selenium supplementation.

Housing and turnout considerations for horses with selenium toxicity require attention to both recovery needs and exposure prevention. Soft footing in stalls and turnout areas reduces stress on damaged hooves during the regeneration period. Deep bedding provides cushioning and comfort for horses with significant lameness. Turnout restrictions may be necessary to prevent overexertion on compromised hooves. Pasture management should exclude areas containing selenium accumulator plants. Water sources should be verified as not contributing to selenium intake. Shelter from weather extremes provides comfort during the recovery period.

Exercise modifications during recovery from selenium toxicity must accommodate the limitations imposed by hoof damage. Complete rest may be necessary for horses with severe lameness or structural compromise. Light hand-walking on soft surfaces may be appropriate for horses with moderate damage, providing controlled exercise while minimizing hoof stress. Gradual return to normal exercise follows restoration of hoof structural integrity, typically requiring nine to twelve months or longer. Swimming or other non-weight-bearing exercise may help maintain fitness in horses with significant hoof limitations. Return to full athletic activity should follow veterinary clearance confirming adequate hoof regeneration.

Monitoring and ongoing care requirements for horses with selenium toxicity history include regular veterinary and farrier assessments throughout the extended recovery period. Blood selenium levels should be rechecked periodically to confirm continued normalization. Hoof evaluation should occur at regular intervals, with more frequent assessment initially and extending intervals as healing progresses. Documentation through photographs helps track progress objectively. Any signs of deterioration or new problems require prompt veterinary evaluation. Long-term monitoring remains important as some effects may become apparent only with time.

Quality of life and use considerations for horses that have experienced selenium toxicity depend on the completeness of recovery. Many horses with mild to moderate damage return to full previous function and enjoy excellent quality of life. Horses with permanent hoof abnormalities may require ongoing supportive shoeing and may not be suitable for demanding athletic activities. The psychological impact of prolonged restricted activity and discomfort should be considered in managing recovering horses. Some horses may need permanent activity modifications based on residual structural weakness. Honest assessment of individual capabilities helps match horses to appropriate activities and ensures their ongoing welfare.

All horse breeds are equally susceptible to selenium toxicity based on their physiology, as the toxic mechanism affects keratin formation and cellular function identically regardless of breed characteristics. The risk of selenosis relates entirely to selenium exposure through geographic location, diet, and supplementation practices rather than any inherent breed susceptibility or resistance. However, certain breed associations may exist through geographic distribution of breed populations in relation to seleniferous regions. Quarter Horses and other breeds common in the Great Plains states of the United States may have higher historical occurrence rates simply due to their prevalence in endemic selenium toxicity regions.

Use and discipline considerations affect selenium toxicity risk primarily through the supplementation practices common in different equine industries. Performance horses in some disciplines may receive more intensive supplementation programs that could increase iatrogenic toxicity risk if not carefully balanced. Breeding operations concerned about white muscle disease in foals may over-supplement selenium during gestation or to neonates. Horses transported from selenium-deficient regions to selenium-adequate or excess areas may receive unnecessary continued supplementation. Horses maintained in areas with known selenium deficiency risk may appropriately receive supplementation that would create toxicity risk if the same practices were followed in selenium-adequate regions.

Genetic testing is not applicable for selenium toxicity susceptibility, as this condition results from nutritional and environmental factors rather than inherited characteristics. Breeding recommendations should focus on management practices rather than genetic selection. Farms in seleniferous regions should implement comprehensive selenium management protocols to protect breeding stock and young horses. Documentation of regional selenium status helps inform appropriate supplementation decisions for breeding operations. Young growing horses may show more severe effects of selenium toxicity on hoof and bone development, making prevention particularly important in breeding populations.

Commonly co-occurring conditions with selenium toxicity result from the multisystem effects of selenium excess and secondary complications of the primary damage. Secondary hoof infections develop when damaged hoof structures allow bacterial invasion, potentially causing abscesses, white line disease, or septic conditions. Laminitis may occur as a secondary complication of systemic inflammation or as a consequence of altered weight-bearing on damaged hooves. Cardiomyopathy from acute selenium toxicity can cause lasting cardiac dysfunction. Hepatic damage may occur from selenium's toxic effects on liver cells. Anemia may develop from effects on red blood cell production or survival. Immunosuppression may result from selenium's effects on immune cell function.

Conditions with similar symptoms to selenium toxicity require differentiation through history, clinical findings, and laboratory evaluation. Other causes of hoof wall defects including chronic laminitis, white line disease, and nutritional deficiencies can produce cracking and structural abnormalities. Dermatophytosis and other skin conditions cause hair loss that might initially be confused with selenosis. Cushing's disease produces hair coat changes including abnormal shedding patterns. Other causes of acute neurological dysfunction must be distinguished from blind staggers syndrome. Environmental factors including sand accumulation and poor hoof care can cause similar-appearing hoof problems. The combination of characteristic hoof and hair changes with elevated selenium levels and appropriate exposure history establishes the diagnosis.

Potential complications of selenium toxicity extend beyond the acute tissue damage. Chronic lameness may persist after hoof regeneration if structural abnormalities remain. Secondary infections of damaged hooves can become severe and life-threatening. Permanent cardiac dysfunction may limit future athletic use. Developmental abnormalities may occur in young growing horses exposed to excess selenium during critical growth periods. Reproductive effects including reduced fertility and fetal abnormalities have been documented in livestock species and may affect horses. Behavioral changes from chronic pain and restricted activity may persist after physical healing. Long-term monitoring helps identify delayed complications that may emerge during recovery or afterward.